Antiviral treatment selection for SARS-CoV-2 pneumonia

M. Bassetti, S. Corcione, S. Dettori, A. Lombardi, T. Lupia, A. Vena, F.G. De Rosa, A. Gori, D.R. Giacobbe

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)985-992
Number of pages8
JournalExpert Review of Respiratory Medicine
Volume15
Issue number8
DOIs
Publication statusPublished - 2021

Keywords

  • antiviral
  • coronavirus
  • COVID-19
  • hydroxychloroquine
  • lopinavir/ritonavir
  • remdesivir
  • SARS-CoV-2
  • antivirus agent
  • lopinavir
  • human
  • treatment outcome
  • Antiviral Agents
  • Humans
  • Hydroxychloroquine
  • Lopinavir
  • Treatment Outcome

Cite this